These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 17728426

  • 1. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC, Shin JG, Kelly DL, Jung DU, Seo YS, Liu KH, Shon JH, Conley RR.
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [Abstract] [Full Text] [Related]

  • 2. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX, Su YA, Bian QT, Wei LH, Zhang RZ, Liu YH, Correll C, Soares JC, Yang FD, Wang SL, Zhang XY.
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [Abstract] [Full Text] [Related]

  • 3. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML, Shen WW, Chen CH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1978-81. PubMed ID: 18848860
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW.
    J Clin Psychiatry; 2002 Sep 12; 63(9):763-71. PubMed ID: 12363115
    [Abstract] [Full Text] [Related]

  • 5. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK, Huang YS, Ree SC, Hsiao CC.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec 01; 34(8):1495-9. PubMed ID: 20732372
    [Abstract] [Full Text] [Related]

  • 6. Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia.
    Hoffer ZS, Roth RL, Mathews M.
    Psychosomatics; 2009 Dec 01; 50(4):317-24. PubMed ID: 19687170
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM, Correll CU, Goff DC, Kirkpatrick B, Marder SR, Vester-Blokland E, Sun W, Carson WH, Pikalov A, Assunção-Talbott S.
    J Clin Psychiatry; 2009 Oct 01; 70(10):1348-57. PubMed ID: 19906340
    [Abstract] [Full Text] [Related]

  • 8. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, Stringfellow J, Ingenito G, Marder SR.
    Arch Gen Psychiatry; 2003 Jul 01; 60(7):681-90. PubMed ID: 12860772
    [Abstract] [Full Text] [Related]

  • 9. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T, Perry CM.
    Drugs; 2004 Jul 01; 64(15):1715-36. PubMed ID: 15257633
    [Abstract] [Full Text] [Related]

  • 10. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.
    Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, Saha A, Ali M, Iwamoto T.
    Schizophr Res; 2003 Jun 01; 61(2-3):123-36. PubMed ID: 12729864
    [Abstract] [Full Text] [Related]

  • 11. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C, Accordini S, Nosè M, Stroup S, Purgato M, Girlanda F, Esposito E, Veronese A, Tansella M, Cipriani A, CHAT (Clozapine Haloperidol Aripiprazole Trial) Study Group.
    J Clin Psychopharmacol; 2011 Jun 01; 31(3):266-73. PubMed ID: 21508849
    [Abstract] [Full Text] [Related]

  • 12. Aripiprazole: what is the role of dopamine D(2) receptor partial agonism?
    Kessler RM.
    Am J Psychiatry; 2007 Sep 01; 164(9):1310-2. PubMed ID: 17728411
    [No Abstract] [Full Text] [Related]

  • 13. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH, Lin SH, Jang FL.
    J Clin Psychopharmacol; 2011 Oct 01; 31(5):563-8. PubMed ID: 21869699
    [Abstract] [Full Text] [Related]

  • 14. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.
    Findling RL, Robb A, Nyilas M, Forbes RA, Jin N, Ivanova S, Marcus R, McQuade RD, Iwamoto T, Carson WH.
    Am J Psychiatry; 2008 Nov 01; 165(11):1432-41. PubMed ID: 18765484
    [Abstract] [Full Text] [Related]

  • 15. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.
    Lee BH, Kim YK, Park SH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun 01; 30(4):714-7. PubMed ID: 16571367
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.
    Kasper S, Lerman MN, McQuade RD, Saha A, Carson WH, Ali M, Archibald D, Ingenito G, Marcus R, Pigott T.
    Int J Neuropsychopharmacol; 2003 Dec 01; 6(4):325-37. PubMed ID: 14609439
    [Abstract] [Full Text] [Related]

  • 17. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks.
    Kane JM, Crandall DT, Marcus RN, Eudicone J, Pikalov A, Carson WH, Swyzen W.
    Schizophr Res; 2007 Sep 01; 95(1-3):143-50. PubMed ID: 17644313
    [Abstract] [Full Text] [Related]

  • 18. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
    Janicak PG, Glick ID, Marder SR, Crandall DT, McQuade RD, Marcus RN, Eudicone JM, Assunção-Talbott S.
    J Clin Psychiatry; 2009 Jan 01; 70(1):25-35. PubMed ID: 19192472
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
    Kuo J, Hwu HG.
    Clin Neuropharmacol; 2008 Jan 01; 31(3):173-5. PubMed ID: 18520984
    [Abstract] [Full Text] [Related]

  • 20. Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole.
    Paulzen M, Gründer G.
    Int J Neuropsychopharmacol; 2007 Feb 01; 10(1):149-51. PubMed ID: 16942633
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.